CONNECT WITH US
HealthTech

HealthTech

New swab test could spare some women a painful biopsy for endometrial cancer

Medical Xpress logo

Published on

Add as a preferred source on Google
New swab test could spare some women a painful biopsy for endometrial cancer

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

A simple vaginal swab may one day help women with abnormal bleeding learn whether they have endometrial cancer without first going through a painful biopsy.

The test, from California-based PinkDx, is being studied at 16 U.S. sites, The Washington Post reported. It's meant for women who already have symptoms, such as bleeding after menopause.

Endometrial cancer starts in the lining of the uterus. Doctors often check for it with a transvaginal ultrasound, which uses a probe in the vagina to measure that lining. They may also do an endometrial biopsy, scraping out a small tissue sample through a thin tube passed into the uterus.

Both can be painful. Biopsies also fail to collect enough tissue about 30% of the time in women past menopause, The Post reported. Sometimes the uterine lining is too thin, or the cervix is too narrow for the instrument.

Meanwhile, endometrial cancer death rates are on the rise. That's partly because aggressive forms of the disease are becoming more common, The Post noted.

"Of all the cancers, this is one that is getting more and more cases being diagnosed every year," Dr. June Hou, a gynecologic oncologist at Columbia University Irving Medical Center in New York City, told The Post. She's leading the PinkDx study there.

Dying cancer cells in the uterus shed bits of genetic material that carry the tumor's fingerprint.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.